跳至主要内容
临床试验/NCT04415216
NCT04415216已完成不适用

Long-term Outcomes Following Drug Eluting Balloon Versus Thin Struts Drug Eluting Stents for Treating In-stent Restenosis: Propensity Score-matched Analysis(DEB-Dragon Registry).

Medical University of Silesia9 个研究点 分布在 1 个国家目标入组 1,369 人开始时间: 2019年10月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,369
试验地点
9
主要终点
TLR

研究概览

简要总结

Data regarding the usefulness of percutaneous coronary intervention (PCI) with drug eluting balloon (DEB) vs. thin struts drug eluting stents (thin-DES) for treating in-stent restenosis (ISR) in every day clinical practice is scarce. We aimed to evaluate comparing the efficacy and safety profile of DEB and thin-DES in DES-ISR.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

接受健康志愿者

入选标准

  • All consecutive patients with DES-ISR who were treated with either paclitaxel-DEB or thin-DES.

排除标准

  • PCI with DES struts thickness >100μm
  • PCI with DEB and thin-DES in the same procedure
  • PCI of other vascular territories during the same procedure
  • PCI in saphenous vain graft or internal mammary artery

结局指标

主要结局

TLR

时间窗: 3 years

target lesion revascularisation

次要结局

  • cardiac death(3 years)
  • DOCE(3 years)
  • myocardial infarction(3 years)
  • TVR(3 years)
  • TV-MI(3 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Wojciech Wańha

MD, PhD

Medical University of Silesia

研究点 (9)

Loading locations...

相似试验